{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.94 vs. cons $4.84",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$110.9B vs. cons $110.7B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Medical care ratio",
      "prediction": "IN-LINE",
      "answer": "pred ~88.3% vs. cons 88.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS outlook",
      "prediction": "LOWER",
      "answer": "guide ~$18.30 vs. cons $18.55 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2H26 adjusted EPS implied by FY outlook",
      "prediction": "LOWER",
      "answer": "guide ~$6.06 vs. cons $6.28 (2H26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 total medical-membership change",
      "prediction": "UNCHANGED",
      "answer": "guide ~-1.3M vs. cons -1.3M (FY26)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest $0.10 EPS beat versus consensus is likely outweighed by FY26 guidance near $18.30 versus $18.55 consensus and lower implied 2H EPS of roughly $6.06 versus $6.28; out-period estimate cuts should persist after the initial reaction.",
  "day5_confidence": "MEDIUM"
}